Literature DB >> 3651780

Percutaneous transhepatic cholangioscopy.

M F Chen1, Y Y Jan, T Y Lee.   

Abstract

Since 1983, percutaneous transhepatic cholangioscopy has been performed in 50 patients for both therapeutic and diagnostic purposes. Percutaneous transhepatic cholangioscopy was used to evaluate the nature of obstructive jaundice in 15 patients and bile duct stones were removed in 35 patients, 27 of whom also had intrahepatic duct stones. The overall success rate for stone removal was 80 per cent. Complications were few with no mortality. Emergency surgery was necessary in two patients, one for subphrenic haematoma, the other for a bile leak. Percutaneous transhepatic cholangioscopy is an effective and safe method for management of biliary stones and is a useful procedure for establishing the diagnosis of obstructive jaundice.

Entities:  

Mesh:

Year:  1987        PMID: 3651780     DOI: 10.1002/bjs.1800740826

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  4 in total

1.  How can cholangioscopy improve the management of intrahepatic stones?

Authors:  T Yamakawa
Journal:  Surg Endosc       Date:  1988       Impact factor: 4.584

Review 2.  Limitations of percutaneous transhepatic cholangioscopy in the removal of complicated biliary calculi.

Authors:  K S Jeng; H J Chiang; S C Shih
Journal:  World J Surg       Date:  1989 Sep-Oct       Impact factor: 3.352

3.  Biliary and pancreatic lithotripsy devices.

Authors:  Rabindra R Watson; Mansour A Parsi; Harry R Aslanian; Adam J Goodman; David R Lichtenstein; Joshua Melson; Udayakumar Navaneethan; Rahul Pannala; Amrita Sethi; Shelby A Sullivan; Nirav C Thosani; Guru Trikudanathan; Arvind J Trindade; John T Maple
Journal:  VideoGIE       Date:  2018-09-26

Review 4.  Difficult Biliary Stones: A Comprehensive Review of New and Old Lithotripsy Techniques.

Authors:  Edoardo Troncone; Michelangela Mossa; Pasquale De Vico; Giovanni Monteleone; Giovanna Del Vecchio Blanco
Journal:  Medicina (Kaunas)       Date:  2022-01-13       Impact factor: 2.430

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.